Radiology

CORSWO stratifies women into four risk levels

Significant increase seen in incidence rates at presentation for women overall, and for those aged 20 to 39, 40 to 74, and 75 years or older

Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients

Neoadjuvant RT strongly recommended for stage II to III rectal cancer but can be omitted for those at lower risk for locoregional recurrence

Odds of alcohol, substance use leading to e-scooter, e-bike injury ED visits higher for males, those age 10 to 17 years

Authors say further reductions will require new discoveries, adoption of emerging interventions

No improvement seen in two-year progression-free survival for radiotherapy with durvalumab versus radiotherapy with cetuximab

Additionally, physician survey respondents say prior authorization challenges put strain on clinic staff

Five-year AUC with addition of previous mammogram images improves current visit mammogram AUC

Aortic artery calcification correlates with coronary artery calcium and is associated with incident major adverse cardiovascular events